In a May 31 announcement, Royal DSM announced acquisition of 66 percent of the shareholding of Firmenich, a Geneva-based food and health company.  Business units include perfumes, foods and beverages and both human and animal nutrition with sales of approximately $12 billion annually.

Thomas Leysen chairman of DSM noted, “DSM-Firmenich will bring together leading creativity and cutting-edge science and innovation.”  He added, “Together we will be able to better serve the needs of customers and deliver compelling growth in returns.”

The transaction will be completed during the first half of 2023.